Halozyme Therapeutics (HALO) Tops Q2 EPS by 47c; raises guidance
Go back to Halozyme Therapeutics (HALO) Tops Q2 EPS by 47c; raises guidance| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 112.45 +2.77 (2.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $109.68 | 52 Week High | $18.39 | |||
| Open | $109.72 | 52 Week Low | $6.96 | |||
| Day High | $112.66 | P/E | N/A | |||
| Day Low | $109.38 | EPS | $-0.58 | |||
| Volume | 10,347,502 | |||||
